Just a few months after announcing a plan to separate its drug and cell therapy businesses into two separate companies, Belgian biotech Galapagos has had a change of heart – and a change of ...

The plan is to stop working on small-molecule drugs, including TYK2 inhibitor GLPG3667, which is in phase 2 trials for systemic lupus erythematosus (SLE) and dermatomyositis, and seek development ...

Objective: To study the clinical and pathological correlations of neuromuscular patients with a high aldolase and normal creatine kinase (CK) in serum at presentation or during a symptomatic ...

Pulmonary hypertension (PH) is a life-threatening condition presenting with symptoms like breathlessness, fatigue and syncope. 1 PH can occur as a complication of systemic autoimmune diseases. 2–4 The ...

Hepatic manifestations in autoimmune disease include chronic active hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and nodular regenerative hyperplasia. These diseases are rare ...